
Feature|Videos|October 26, 2026
Making the Case: How to Do a Literature Review
Systematic or scoping? This webinar covers the PICO and PCC frameworks, MeSH search strings, citation searching, medical librarians, screening rounds, and PROSPERO registration.
Advertisement
Advertisement
A literature review is not a laundry list of everything published on a topic. Whether it stands alone or opens an original research paper, it makes the case for why the work matters. In the third installment of a 4-part webinar series from the International Journal of MS Care, editor in chief François Bethoux, MD, and associate editor Mary Alissa Willis, MD, walk through how to build one.
Related to this article

The professor of neurology at UT Southwestern Medical Center discussed emerging trials, proposed changes to myelitis diagnostic criteria and nomenclature, and the unmet needs raised by patients at this year’s symposium.

A new FDA filing seeks to expand cenobamate's epilepsy indication to primary generalized tonic-clonic seizures, based on positive phase 3 trial data.

Gefurulimab (Klygefa), a once-weekly, self-administered complement C5 inhibitor from Alexion and AstraZeneca, is now approved in the US for adults with AChR-antibody-positive generalized myasthenia gravis.

Allison B. Reiss, MD, associate professor of medicine at NYU Grossman Long Island School of Medicine discussed the often-overlooked early signs of early-onset Alzheimer disease.

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is National Epilepsy Awareness Month!

Nick Cunniffe, MD, PhD, assistant professor and consultant neurologist at the University of Cambridge, discusses lessons from a decade of proof-of-concept remyelination trials in MS.
Advertisement
Advertisement


